Sensei Biotherapeutics Inc (SNSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,405 | -36,794 | -27,428 | -17,743 | -7,972 |
| Depreciation Amortization | 334 | 685 | 356 | 220 | 98 |
| Other Working Capital | -667 | 117 | 24 | -2,564 | -4,245 |
| Other Operating Activity | 1,988 | 5,733 | 4,657 | 3,273 | 1,352 |
| Operating Cash Flow | $-10,750 | $-30,259 | $-22,391 | $-16,814 | $-10,767 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 12,212 | -141,410 | -147,557 | -147,145 | 0 |
| PPE Investments | -19 | -1,708 | -1,173 | -1,103 | -487 |
| Investing Cash Flow | $12,193 | $-143,118 | $-148,730 | $-148,248 | $-487 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -133 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 238 | 140,623 | 140,595 | 140,595 | 140,595 |
| Other Financing Activity | 14 | 23,317 | 23,463 | 23,470 | 23,481 |
| Financing Cash Flow | $119 | $163,940 | $164,058 | $164,065 | $164,076 |
| Beginning Cash Position | 7,159 | 16,596 | 16,596 | 16,596 | 16,596 |
| End Cash Position | 8,721 | 7,159 | 9,533 | 15,599 | 169,418 |
| Net Cash Flow | $1,562 | $-9,437 | $-7,063 | $-997 | $152,822 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,750 | -30,259 | -22,391 | -16,814 | -10,767 |
| Capital Expenditure | -19 | -2,026 | -1,491 | -1,103 | -487 |
| Free Cash Flow | -10,769 | -32,285 | -23,882 | -17,917 | -11,254 |